Incidence, Pathophysiology, and Treatment of Complications During Dobutamine-Atropine Stress Echocardiography

Geleijnse, Marcel L.; Krenning, Boudewijn J.; Nemes, Attila; Dalen, Bas M. van; Soliman, Osama Ibrahim Ibrahim; Cate, Folkert J. ten; Schinkel, Arend F. L.; Boersma, Eric; Simoons, Maarten L.

doi:10.1161/circulationaha.109.859264

Cited by 101 publications

(110 citation statements)

References 139 publications

(194 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…MI (<0.02%) and death (<0.002%) as complications are very rare. 167 Side effects or complications can be treated by intravenous injection of adrenergic β-receptorblocking agents such as metoprolol or esmolol.…”

Section: Dobutaminementioning

confidence: 99%

Exercise Standards for Testing and Training

Fletcher¹,

Ades²,

Kligfield³

et al. 2013

Circulation

1,620

760

View full text Add to dashboard Cite

Section: Dobutaminementioning

confidence: 99%

Exercise Standards for Testing and Training

Fletcher¹,

Ades²,

Kligfield³

et al. 2013

Circulation

1,620

760

View full text Add to dashboard Cite

“…2). In view of this finding, a coronary vasospasm triggered by esmolol was diagnosed.Coronary spam during the stress dobutamine echocardiography is a rare phenomenon with a reported prevalence of 0.4% [6,7]. Ergonovine or methylergonovine challenges are valuable tools for a definitive diagnosis of coronary spasm [8].…”

mentioning

confidence: 99%

Coronary vasospasm after dobutamine stress echocardiogram triggered by esmolol

Martínez¹,

Riquelme²,

Ayala³

et al. 2015

International Journal of Cardiology

View full text Add to dashboard Cite

“…The clinical characteristics of patients who have a hypertensive response during DSE include those patients with pre-existing hypertension, patients with a high blood pressure at the onset of the study and those treated with β-blockers where unopposed α-blocker stimulation can result in peripheral vasoconstriction as well as an elevated blood pressure [15,16]. Our patient did not have a history of high blood pressure prior to nor documented during his hospitalization and he was not treated with β-blockers.…”

Section: Discussionmentioning

confidence: 99%

Sinus Node Dysfunction Unmasked during Dobutamine Stress Echocardiography

Khan

Bustros²,

Mitre³

et al. 2011

Cardiology

View full text Add to dashboard Cite

Sinus bradycardia and associated isorhythmic AV dissociation may be seen during dobutamine stress echocardiography. This phenomenon is usually considered a benign peri-procedural event and is thought to be secondary to the Bezold-Jarisch reflex, with profound heart rate decrease secondary to a marked increased in vagal efferent discharge. To the best of our knowledge, dobutamine stress echocardiography unmasking clinically relevant sinus node dysfunction has never been reported. We report a case of a 50-year-old man presenting with chest pain and a history of syncope, who had worsening sinus bradycardia with isorhythmic AV dissociation during dobutamine stress echocardiography. An invasive electrophysiological study revealed marked sinus node dysfunction. The patient was referred for the insertion of a permanent pacemaker for sinus node dysfunction, chronotropic incompetence and symptomatic bradycardia. Dobutamine-associated bradycardia may not always be a benign peri-procedural physiologic effect, as in this case it may unmask clinically significant sinus node dysfunction.

show abstract

Incidence, Pathophysiology, and Treatment of Complications During Dobutamine-Atropine Stress Echocardiography

Cited by 101 publications

References 139 publications

Exercise Standards for Testing and Training

Exercise Standards for Testing and Training

Coronary vasospasm after dobutamine stress echocardiogram triggered by esmolol

Sinus Node Dysfunction Unmasked during Dobutamine Stress Echocardiography

Contact Info

Product

Resources

About